Overview and recommendations for medical screening and diagnostic evaluation for postdeployment lung disease in returning US warfighters.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22588477.
- Also identified by DOI 10.1097/JOM.0b013e31825297ba.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To review inhalational exposures and respiratory disease risks in US military personnel deployed to Iraq and Afghanistan and to develop consensus recommendations for medical screening and diagnostic referral. A Working Group of physicians and exposure scientists from academia and from the Departments of Defense and Veterans Affairs was convened in February 2010. Despite uncertainty about the number of people affected and risk factors for adverse pulmonary outcomes in this occupational setting, the Working Group recommended: (1) standardized approaches to pre- and postdeployment medical surveillance; (2) criteria for medical referral and diagnosis; and (3) case definitions for major deployment-related lung diseases. There is a need for targeted, practical medical surveillance for lung diseases and for a standardized diagnostic approach for all symptomatic deployed personnel.
Medical subject headings
- Lung Diseases
- Mass Screening
- Military Personnel
- Practice Guidelines as Topic
- Referral and Consultation
- Veterans